[{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":538,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.62,"TPM_sd":13.53,"TPM_min":0,"TPM_25th_percentile":2.15,"TPM_median":3.99,"TPM_75th_percentile":8.52,"TPM_max":118.93},{"x_label":"Acute Lymphoblastic Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 613)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":75,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Lymphoblastic Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000220","MONDO":"MONDO_0004967","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.8,"TPM_sd":12.58,"TPM_min":0.04,"TPM_25th_percentile":0.99,"TPM_median":2.27,"TPM_75th_percentile":5.9,"TPM_max":99.31},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":168,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.59,"TPM_sd":1.01,"TPM_min":0,"TPM_25th_percentile":0.11,"TPM_median":0.24,"TPM_75th_percentile":0.53,"TPM_max":7},{"x_label":"Acute Myeloid Leukemia  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 210)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":42,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Acute Myeloid Leukemia","GTEx_tissue_subgroup":"","EFO":"EFO_0000222","MONDO":"MONDO_0018874","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.47,"TPM_sd":0.38,"TPM_min":0,"TPM_25th_percentile":0.2,"TPM_median":0.38,"TPM_75th_percentile":0.55,"TPM_max":1.62},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":43,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.56,"TPM_sd":4.67,"TPM_min":0.21,"TPM_25th_percentile":0.95,"TPM_median":1.62,"TPM_75th_percentile":2.32,"TPM_max":30.55},{"x_label":"Adamantinomatous Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 58)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":15,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Adamantinomatous Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000069","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.37,"TPM_sd":1.02,"TPM_min":0.13,"TPM_25th_percentile":0.61,"TPM_median":1.34,"TPM_75th_percentile":1.73,"TPM_max":4.1},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":45,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.53,"TPM_sd":87.4,"TPM_min":0.12,"TPM_25th_percentile":1.24,"TPM_median":3.59,"TPM_75th_percentile":8.96,"TPM_max":590.45},{"x_label":"Atypical Teratoid Rhabdoid Tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 59)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Atypical Teratoid Rhabdoid Tumor","GTEx_tissue_subgroup":"","EFO":"EFO_1002008","MONDO":"MONDO_0020560","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.13,"TPM_sd":3.88,"TPM_min":0.74,"TPM_25th_percentile":1.47,"TPM_median":2.72,"TPM_75th_percentile":6.16,"TPM_max":15.03},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.41,"TPM_sd":4.73,"TPM_min":0,"TPM_25th_percentile":0.14,"TPM_median":0.44,"TPM_75th_percentile":0.62,"TPM_max":10.87},{"x_label":"Chordoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 8)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Chordoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0008978","MONDO":"MONDO_0008978","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.86,"TPM_sd":8.17,"TPM_min":0,"TPM_25th_percentile":0.15,"TPM_median":0.3,"TPM_75th_percentile":7.3,"TPM_max":14.29},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.94,"TPM_sd":8.84,"TPM_min":1.42,"TPM_25th_percentile":2.75,"TPM_median":5.18,"TPM_75th_percentile":11.83,"TPM_max":27.75},{"x_label":"Choroid plexus carcinoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 15)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Choroid plexus carcinoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016718","MONDO":"MONDO_0016718","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.35,"TPM_sd":16.29,"TPM_min":0.59,"TPM_25th_percentile":1.06,"TPM_median":2.68,"TPM_75th_percentile":4.02,"TPM_max":38.38},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":12,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":50.74,"TPM_sd":42.75,"TPM_min":2.38,"TPM_25th_percentile":19.45,"TPM_median":38.77,"TPM_75th_percentile":73.32,"TPM_max":119.86},{"x_label":"CNS Embryonal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"CNS Embryonal tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005784","MONDO":"MONDO_0018843","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.81,"TPM_sd":4.19,"TPM_min":0.35,"TPM_25th_percentile":2.09,"TPM_median":4,"TPM_75th_percentile":5.8,"TPM_max":13.48},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.52,"TPM_sd":0.35,"TPM_min":0.18,"TPM_25th_percentile":0.28,"TPM_median":0.48,"TPM_75th_percentile":0.62,"TPM_max":1.45},{"x_label":"Craniopharyngioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Craniopharyngioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000209","MONDO":"MONDO_0002787","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.33,"TPM_sd":7.05,"TPM_min":0.19,"TPM_25th_percentile":0.26,"TPM_median":0.34,"TPM_75th_percentile":6.4,"TPM_max":12.47},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":22,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":18.54,"TPM_sd":16.25,"TPM_min":1.99,"TPM_25th_percentile":6.76,"TPM_median":14.22,"TPM_75th_percentile":22.52,"TPM_max":66.72},{"x_label":"Diffuse hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 28)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016680","MONDO":"MONDO_0016680","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.04,"TPM_sd":11.48,"TPM_min":1.22,"TPM_25th_percentile":2.65,"TPM_median":7.03,"TPM_75th_percentile":10.5,"TPM_max":32.11},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.02,"TPM_sd":5.35,"TPM_min":0.63,"TPM_25th_percentile":1.19,"TPM_median":1.72,"TPM_75th_percentile":4.55,"TPM_max":12},{"x_label":"Diffuse intrinsic pontine glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse intrinsic pontine glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.44,"TPM_sd":6.87,"TPM_min":1.8,"TPM_25th_percentile":4.16,"TPM_median":8.19,"TPM_75th_percentile":15.42,"TPM_max":17.81},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.41,"TPM_sd":9.4,"TPM_min":0.39,"TPM_25th_percentile":2.96,"TPM_median":7.03,"TPM_75th_percentile":12.3,"TPM_max":61.66},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 164)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":48,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.85,"TPM_sd":3.83,"TPM_min":0.17,"TPM_25th_percentile":1.85,"TPM_median":4.02,"TPM_75th_percentile":6.87,"TPM_max":16.79},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.59,"TPM_sd":3.26,"TPM_min":0.51,"TPM_25th_percentile":1.64,"TPM_median":4.15,"TPM_75th_percentile":7.4,"TPM_max":11.77},{"x_label":"Dysembryoplastic neuroepithelial tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 39)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Dysembryoplastic neuroepithelial tumor","GTEx_tissue_subgroup":"","EFO":"EFO_0005551","MONDO":"MONDO_0005505","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.45,"TPM_sd":4.7,"TPM_min":4.91,"TPM_25th_percentile":6.26,"TPM_median":7.26,"TPM_75th_percentile":12.81,"TPM_max":17.78},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":116,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.55,"TPM_sd":1.8,"TPM_min":0.03,"TPM_25th_percentile":0.58,"TPM_median":0.94,"TPM_75th_percentile":1.77,"TPM_max":10.83},{"x_label":"Ependymoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 163)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":47,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ependymoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000028","MONDO":"MONDO_0016698","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.96,"TPM_sd":2.82,"TPM_min":0.07,"TPM_25th_percentile":0.7,"TPM_median":1.91,"TPM_75th_percentile":4.84,"TPM_max":12.31},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.64,"TPM_sd":8.49,"TPM_min":0.77,"TPM_25th_percentile":1.36,"TPM_median":5.62,"TPM_75th_percentile":14.67,"TPM_max":24.07},{"x_label":"Ewing sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 13)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ewing sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000174","MONDO":"MONDO_0012817","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.83,"TPM_sd":4.21,"TPM_min":0,"TPM_25th_percentile":3.38,"TPM_median":6.77,"TPM_75th_percentile":7.24,"TPM_max":7.72},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":64,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.04,"TPM_sd":1.83,"TPM_min":0.16,"TPM_25th_percentile":0.83,"TPM_median":1.29,"TPM_75th_percentile":2.82,"TPM_max":8.92},{"x_label":"Ganglioglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 80)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":16,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Ganglioglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0003094","MONDO":"MONDO_0016733","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.33,"TPM_sd":2.55,"TPM_min":0.3,"TPM_25th_percentile":0.86,"TPM_median":1.25,"TPM_75th_percentile":2.55,"TPM_max":8.99},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":17,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.81,"TPM_sd":10.28,"TPM_min":0.32,"TPM_25th_percentile":1.34,"TPM_median":2.67,"TPM_75th_percentile":5.88,"TPM_max":40.13},{"x_label":"Glial-neuronal tumor  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 24)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Glial-neuronal tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0016729","MONDO":"MONDO_0016729","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.12,"TPM_sd":9.13,"TPM_min":0.53,"TPM_25th_percentile":1.15,"TPM_median":5.93,"TPM_75th_percentile":12.82,"TPM_max":22.46},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":125,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.29,"TPM_sd":10.5,"TPM_min":0.16,"TPM_25th_percentile":2.44,"TPM_median":5.2,"TPM_75th_percentile":12.27,"TPM_max":53.73},{"x_label":"High-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 175)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":50,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"High-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0100342","MONDO":"MONDO_0100342","GTEx_tissue_subgroup_UBERON":"","TPM_mean":9.15,"TPM_sd":21.94,"TPM_min":0.34,"TPM_25th_percentile":0.95,"TPM_median":3.63,"TPM_75th_percentile":7.27,"TPM_max":133.7},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.44,"TPM_sd":3.92,"TPM_min":1.19,"TPM_25th_percentile":1.92,"TPM_median":5.38,"TPM_75th_percentile":8.59,"TPM_max":10.25},{"x_label":"Infant-type hemispheric glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Infant-type hemispheric glioma","GTEx_tissue_subgroup":"","EFO":"EFO_0005543","MONDO":"MONDO_0014695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":10.62,"TPM_sd":10,"TPM_min":0.66,"TPM_25th_percentile":3.42,"TPM_median":9.62,"TPM_75th_percentile":16.83,"TPM_max":22.57},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":334,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":4.13,"TPM_sd":3.15,"TPM_min":0.11,"TPM_25th_percentile":1.98,"TPM_median":3.55,"TPM_75th_percentile":5.54,"TPM_max":23.12},{"x_label":"Low-grade glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 412)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":78,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Low-grade glioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0021637","MONDO":"MONDO_0021637","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.95,"TPM_sd":4.31,"TPM_min":0.05,"TPM_25th_percentile":1.64,"TPM_median":2.8,"TPM_75th_percentile":5.06,"TPM_max":34.48},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":206,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":41.54,"TPM_sd":33.75,"TPM_min":1.67,"TPM_25th_percentile":19.47,"TPM_median":31.38,"TPM_75th_percentile":49.48,"TPM_max":212.34},{"x_label":"Medulloblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 237)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Medulloblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0002939","MONDO":"MONDO_0007959","GTEx_tissue_subgroup_UBERON":"","TPM_mean":32.39,"TPM_sd":28.81,"TPM_min":1.35,"TPM_25th_percentile":13.58,"TPM_median":23.41,"TPM_75th_percentile":43.94,"TPM_max":128.46},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":31,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.72,"TPM_sd":0.56,"TPM_min":0,"TPM_25th_percentile":0.38,"TPM_median":0.58,"TPM_75th_percentile":0.84,"TPM_max":2.56},{"x_label":"Meningioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 42)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":11,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Meningioma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016642","MONDO":"MONDO_0016642","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.76,"TPM_sd":0.68,"TPM_min":0.04,"TPM_25th_percentile":0.3,"TPM_median":0.42,"TPM_75th_percentile":1.12,"TPM_max":2.05},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":304,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":51.98,"TPM_sd":42.32,"TPM_min":0.81,"TPM_25th_percentile":25.48,"TPM_median":39.79,"TPM_75th_percentile":63.6,"TPM_max":323.67},{"x_label":"Neuroblastoma  (Dataset = All Cohorts, Specimen = Pediatric Primary and Relapse Tumors, N = 318)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"All Cohorts","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":44.12,"TPM_sd":43.03,"TPM_min":0.3,"TPM_25th_percentile":14.66,"TPM_median":35.8,"TPM_75th_percentile":51.05,"TPM_max":141.13},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":129,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":80.85,"TPM_sd":50.05,"TPM_min":1.74,"TPM_25th_percentile":45.86,"TPM_median":69.8,"TPM_75th_percentile":109.02,"TPM_max":323.67},{"x_label":"Neuroblastoma  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 137)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":8,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Neuroblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000621","MONDO":"MONDO_0005072","GTEx_tissue_subgroup_UBERON":"","TPM_mean":65.84,"TPM_sd":44.94,"TPM_min":13.26,"TPM_25th_percentile":38.32,"TPM_median":48.88,"TPM_75th_percentile":88.86,"TPM_max":141.13},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.52,"TPM_sd":0.28,"TPM_min":0,"TPM_25th_percentile":0.29,"TPM_median":0.52,"TPM_75th_percentile":0.69,"TPM_max":1.07},{"x_label":"Neurofibroma/Plexiform  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 20)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Neurofibroma/Plexiform","GTEx_tissue_subgroup":"","EFO":"EFO_0000658","MONDO":"MONDO_0003304","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.5,"TPM_sd":0.26,"TPM_min":0.1,"TPM_25th_percentile":0.36,"TPM_median":0.56,"TPM_75th_percentile":0.63,"TPM_max":0.83},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":36,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.83,"TPM_sd":2.38,"TPM_min":0.01,"TPM_25th_percentile":1.51,"TPM_median":2.5,"TPM_75th_percentile":3.24,"TPM_max":12.58},{"x_label":"Oligodendroglioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 62)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":26,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Oligodendroglioma","GTEx_tissue_subgroup":"","EFO":"EFO_0000632","MONDO":"MONDO_0016695","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.24,"TPM_sd":2,"TPM_min":0.06,"TPM_25th_percentile":0.74,"TPM_median":1.71,"TPM_75th_percentile":3.47,"TPM_max":8.05},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.71,"TPM_sd":3.89,"TPM_min":1.07,"TPM_25th_percentile":2.99,"TPM_median":3.98,"TPM_75th_percentile":8.8,"TPM_max":11.34},{"x_label":"Pilocytic astrocytoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 10)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pilocytic astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016691","MONDO":"MONDO_0016691","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.43,"TPM_sd":6.19,"TPM_min":1.52,"TPM_25th_percentile":2.96,"TPM_median":4.39,"TPM_75th_percentile":8.88,"TPM_max":13.38},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":10,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":19.66,"TPM_sd":13.73,"TPM_min":2.23,"TPM_25th_percentile":7.61,"TPM_median":17.91,"TPM_75th_percentile":34.27,"TPM_max":35.57},{"x_label":"Pineoblastoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 14)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Pineoblastoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000475","MONDO":"MONDO_0016722","GTEx_tissue_subgroup_UBERON":"","TPM_mean":23.72,"TPM_sd":37.1,"TPM_min":1.76,"TPM_25th_percentile":1.79,"TPM_median":7.14,"TPM_75th_percentile":29.07,"TPM_max":78.85},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":7,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.51,"TPM_sd":2.08,"TPM_min":0,"TPM_25th_percentile":0.16,"TPM_median":0.47,"TPM_75th_percentile":2.04,"TPM_max":5.72},{"x_label":"Sarcoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 16)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.53,"TPM_sd":3.91,"TPM_min":0.09,"TPM_25th_percentile":0.48,"TPM_median":0.72,"TPM_75th_percentile":1.27,"TPM_max":10.72},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":23,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.81,"TPM_sd":0.43,"TPM_min":0.23,"TPM_25th_percentile":0.51,"TPM_median":0.71,"TPM_75th_percentile":1.08,"TPM_max":1.86},{"x_label":"Schwannoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 27)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":4,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Schwannoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000693","MONDO":"MONDO_0002546","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.01,"TPM_sd":0.77,"TPM_min":0.33,"TPM_25th_percentile":0.54,"TPM_median":0.8,"TPM_75th_percentile":1.27,"TPM_max":2.08},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":6,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":8.04,"TPM_sd":12.82,"TPM_min":0.45,"TPM_25th_percentile":0.95,"TPM_median":2.45,"TPM_75th_percentile":7.35,"TPM_max":33.47},{"x_label":"Teratoma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 9)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"PBTA","Disease":"Teratoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0002601","MONDO":"MONDO_0002601","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.23,"TPM_sd":0.14,"TPM_min":0.07,"TPM_25th_percentile":0.17,"TPM_median":0.27,"TPM_75th_percentile":0.31,"TPM_max":0.35},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":124,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.66,"TPM_sd":3.68,"TPM_min":0.2,"TPM_25th_percentile":3.7,"TPM_median":6.21,"TPM_75th_percentile":9.21,"TPM_max":18.48},{"x_label":"Wilms tumor  (Dataset = TARGET, Specimen = Pediatric Primary and Relapse Tumors, N = 129)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000213420","Gene_symbol":"GPC2","PMTL":"Relevant Molecular Target (PMTL version 3.1)","Dataset":"TARGET","Disease":"Wilms tumor","GTEx_tissue_subgroup":"","EFO":"MONDO_0006058","MONDO":"MONDO_0006058","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.42,"TPM_sd":3.03,"TPM_min":2.15,"TPM_25th_percentile":5.35,"TPM_median":5.95,"TPM_75th_percentile":8.88,"TPM_max":9.75}]